A high affinity nanobody against endothelin receptor type B: a new approach to the treatment of melanoma
Crossref DOI link: https://doi.org/10.1007/s11033-020-05313-w
Published Online: 2020-02-20
Published Print: 2020-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ji, Lili
Dong, Changsheng http://orcid.org/0000-0002-6984-8937
Fan, Reiwen
Qi, Shuhui
Text and Data Mining valid from 2020-02-20
Version of Record valid from 2020-02-20
Article History
Received: 7 June 2019
Accepted: 7 February 2020
First Online: 20 February 2020
Compliance with ethical standards
:
: All authors declare that there are no conflicts of interest.